# Effects of LDX on Cognitive Processes and Appetite

> **NCT04181957** · NA · TERMINATED · sponsor: **University of Birmingham** · enrollment: 22 (actual)

## Conditions studied

- Binge Eating
- Eating Behavior

## Interventions

- **DRUG:** Placebo oral tablet
- **DRUG:** Lisdexamfetamine Dimesylate

## Key facts

- **NCT ID:** NCT04181957
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-03-17
- **Final completion:** 2020-03-17
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** COVID-19
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181957, "Effects of LDX on Cognitive Processes and Appetite". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04181957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*